Japan Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
Condition:   Gastric or Gastroesophageal Cancer Intervention:   Drug: FPA144 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
Condition:   Gastric or Gastroesophageal Cancer Intervention:   Drug: FPA144 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
Condition:   Gastric or Gastroesophageal Cancer Intervention:   Drug: FPA144 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
Condition:   Gastric or Gastroesophageal Cancer Intervention:   Drug: FPA144 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
Condition:   Gastric or Gastroesophageal Cancer Intervention:   Drug: FPA144 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer
Condition:   Gastric or Gastroesophageal Cancer Intervention:   Drug: FPA144 Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Conditions:   Respiratory Syncytial Virus (RSV);   Respiratory Viral Infection;   Acute Disease Intervention:   Sponsors:   Institute for Clinical Effectiveness, Japan;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials